Kashimura Akinori, Kimura Masahiro, Okawa Kazuaki, Suzuki Hirotaka, Ukita Atsushi, Wakita Satoshi, Okazaki Kana, Ohno Misa, Bauer Peter O, Sakaguchi Masayoshi, Sugahara Yasusato, Oyama Fumitaka
Department of Applied Chemistry, Kogakuin University, Hachioji, Tokyo 192-0015, Japan.
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Int J Mol Sci. 2015 Feb 13;16(2):4028-42. doi: 10.3390/ijms16024028.
Mouse acidic mammalian chitinase (AMCase) plays important physiological roles in defense and nutrition. AMCase is composed of an N-terminal catalytic domain (CatD) and a C-terminal chitin-binding domain (CBD). We expressed CatD of mouse AMCase as a recombinant fusion protein with Protein A and V5-His in Escherichia coli (Protein A-CatD-V5-His), evaluated its functional properties and compared them to the full-length AMCase (Protein A-AMCase-V5-His). Under our experimental conditions, the chitinolytic activity of both proteins against 4-nitrophenyl N,N'-diacetyl-β-D-chitobioside was equivalent with regard to their specific enzymatic activities, optimal pH and temperature as well as to the pH and temperature stability. CatD bound to chitin beads and cleaved the N-acetylglucosamine hexamer, colloidal and crystalline chitin as well as the shrimp shell, and released primarily N,N'-diacetylchitobiose fragments at pH 2.0. These results indicate that the primary structure of CatD is sufficient to form a proper tertiary structure required for chitinolytic activity, recognize chitin substrates and degrade them in the absence of a CBD. Our recombinant proteins can be used for further studies evaluating pathophysiological roles of AMCase in different diseases.
小鼠酸性哺乳动物几丁质酶(AMCase)在防御和营养方面发挥着重要的生理作用。AMCase由一个N端催化结构域(CatD)和一个C端几丁质结合结构域(CBD)组成。我们在大肠杆菌中表达了小鼠AMCase的CatD,将其作为与蛋白A和V5-His的重组融合蛋白(蛋白A-CatD-V5-His),评估其功能特性,并与全长AMCase(蛋白A-AMCase-V5-His)进行比较。在我们的实验条件下,就其比酶活性、最佳pH值和温度以及pH值和温度稳定性而言,这两种蛋白对4-硝基苯基N,N'-二乙酰-β-D-壳二糖的几丁质分解活性相当。CatD与几丁质珠结合并切割N-乙酰葡糖胺六聚体、胶体几丁质和结晶几丁质以及虾壳,并在pH 2.0时主要释放N,N'-二乙酰壳二糖片段。这些结果表明,CatD的一级结构足以形成几丁质分解活性所需的合适三级结构,识别几丁质底物并在没有CBD的情况下将其降解。我们的重组蛋白可用于进一步研究评估AMCase在不同疾病中的病理生理作用。